MetaADEDB 2.0 @ LMMD
oxybutynin
(XIQVNETUBQGFHX-UHFFFAOYSA-N)
Structure
SMILES
CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC
Type(s)
Approved; Investigational
ATC code(s)
G04BD04
Molecular Formula:
C22H31NO3
Molecular Weight:
357.486
Log P:
3.3429
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
1
TPSA:
49.77
CAS Number(s):
5633-20-5
Synonym(s)
1.
oxybutynin
2.
4-(diethylamino)-2-butynyl-alpha-cyclohexyl-alpha-hydroxybenzeneacetate
3.
4-(diethylamino)-2-butynyl-alpha-phenylcyclohexaneglycolate
4.
Apo-Oxybutynin
5.
Contimin
6.
Cystonorm
7.
Cystrin
8.
Ditropan
9.
Dresplan
10.
Dridase
11.
Driptane
12.
Gen-Oxybutynin
13.
Novo-Oxybutynin
14.
Nu-Oxybutyn
15.
Oxyb AbZ
16.
Oxybugamma
17.
Oxybutin Holsten
18.
Oxybuton
19.
Oxybutynin AL
20.
Oxybutynin AZU
21.
Oxybutynin Heumann
22.
Oxybutynin Hexal
23.
Oxybutynin Stada
24.
Oxybutynin-Puren
25.
Oxybutynin-ratiopharm
26.
Oxymedin
27.
Oxytrol
28.
PMS-Oxybutynin
29.
Pollakisu
30.
Renamel
31.
Ryol
32.
Spasmex Oxybutynin
33.
Spasyt
34.
Tavor
35.
Zatur
36.
gelnique
37.
oxybutynin chloride
38.
oxybutynin hydrochloride
39.
oxybutynin von ct
External Link(s)
MeSHC005419
PubChem Compound4634
BindingDB50165019
ChEBI144551
7856
CHEMBLCHEMBL1231
DrugBankDB01062
DrugCentral2028
IUPHAR/BPS Guide to PHARMACOLOGY359
KEGGcpd:C07360
dr:D00465
Therapeutic Target DatabaseD0F5LH
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 1829
Canada Vigilance: 14
Canada Vigilance
SIDER
US FAERS
2Application site erythemaFAERS: 473
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
3Product adhesion issueFAERS: 463
Canada Vigilance: 1
Canada Vigilance
US FAERS
4Application site pruritusFAERS: 287OFFSIDES
SIDER
US FAERS
5Product quality issueFAERS: 278
Canada Vigilance: 2
Canada Vigilance
US FAERS
6PruritusFAERS: 276SIDER
US FAERS
7ErythemaFAERS: 226OFFSIDES
SIDER
US FAERS
8Application site rashFAERS: 169OFFSIDES
SIDER
US FAERS
9Product use issueFAERS: 135US FAERS
10Drug administered at inappropriate siteFAERS: 132US FAERS
11Inappropriate schedule of drug administrationFAERS: 131US FAERS
12Application site irritationFAERS: 122US FAERS
13DizzinessFAERS: 116
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
14Application site painFAERS: 112SIDER
US FAERS
15Skin irritationFAERS: 102US FAERS
16Drug effect incompleteFAERS: 69US FAERS
17ConstipationFAERS: 68
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
18Incorrect drug administration durationFAERS: 65US FAERS
19Wrong technique in drug usage processFAERS: 63OFFSIDES
US FAERS
20PainFAERS: 60OFFSIDES
SIDER
US FAERS
21Wrong technique in product usage processFAERS: 60US FAERS
22NauseaFAERS: 59
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
23HeadacheFAERS: 57SIDER
US FAERS
24Product closure removal difficultFAERS: 54US FAERS
25Rash erythematousFAERS: 54US FAERS
26Drug effect delayedFAERS: 53US FAERS
27Expired product administeredFAERS: 53US FAERS
28Product packaging issueFAERS: 53US FAERS
29Application site burnFAERS: 49SIDER
US FAERS
30HypersensitivityFAERS: 44SIDER
US FAERS
31Back PainFAERS: 40SIDER
US FAERS
32Urinary RetentionFAERS: 39SIDER
US FAERS
33SomnolenceFAERS: 38
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
34Urinary IncontinenceFAERS: 363930473
15977961
CTD
US FAERS
35DiscomfortFAERS: 35SIDER
US FAERS
36MalaiseFAERS: 35SIDER
US FAERS
37Burning sensationFAERS: 33US FAERS
38FatigueFAERS: 31
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
39Feeling abnormalFAERS: 30SIDER
US FAERS
40DysuriaFAERS: 28OFFSIDES
SIDER
US FAERS
41Adverse eventFAERS: 26OFFSIDES
US FAERS
42Unevaluable eventFAERS: 26OFFSIDES
US FAERS
43Urinary tract infectionFAERS: 26SIDER
US FAERS
44NocturiaFAERS: 25OFFSIDES
SIDER
US FAERS
45OverdoseFAERS: 25OFFSIDES
US FAERS
46Application site discomfortFAERS: 24US FAERS
47UrticariaFAERS: 24SIDER
US FAERS
48AnxietyFAERS: 22OFFSIDES
SIDER
US FAERS
49AmnesiaFAERS: 21SIDER
US FAERS
50Application site reactionFAERS: 21SIDER
US FAERS
51Application site swellingFAERS: 21US FAERS
52Drug ineffective for unapproved indicationFAERS: 21US FAERS
53AgitationFAERS: 19
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
54AstheniaFAERS: 19
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
SIDER
US FAERS
55Abdominal discomfortFAERS: 18SIDER
US FAERS
56CystitisFAERS: 18SIDER
US FAERS
57Application site exfoliationFAERS: 17US FAERS
58Drug administration errorFAERS: 17US FAERS
59Drug prescribing errorFAERS: 17US FAERS
60Dry skinFAERS: 17OFFSIDES
SIDER
US FAERS
61Skin reactionFAERS: 16US FAERS
62Application site vesiclesFAERS: 15SIDER
US FAERS
63Chest PainFAERS: 14OFFSIDES
SIDER
US FAERS
64Medication residue presentFAERS: 14US FAERS
65Pharmaceutical product complaintFAERS: 14US FAERS
66ThirstFAERS: 14SIDER
US FAERS
67ArthralgiaFAERS: 13SIDER
US FAERS
68Incorrect dose administeredFAERS: 13US FAERS
69Peripheral swellingFAERS: 13US FAERS
70Abdominal PainFAERS: 12
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
71DeliriumFAERS: 1217163294CTD
US FAERS
72Drug dose omissionFAERS: 12US FAERS
73Product substitution issueFAERS: 12US FAERS
74SwellingFAERS: 12US FAERS
75Therapeutic response unexpectedFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
76DehydrationFAERS: 11OFFSIDES
US FAERS
77DisorientationFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
78Drug effect variableFAERS: 11US FAERS
79Medication ErrorFAERS: 11US FAERS
80Application site papulesFAERS: 10US FAERS
81Application site urticariaFAERS: 10OFFSIDES
US FAERS
82Application site warmthFAERS: 10US FAERS
83ChromaturiaFAERS: 10US FAERS
84Drug DependenceFAERS: 10US FAERS
85DysgeusiaFAERS: 10SIDER
US FAERS
86Intentional product misuseFAERS: 10US FAERS
87MyalgiaFAERS: 10US FAERS
88PalpitationsFAERS: 10
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
89Product residue presentFAERS: 10US FAERS
90VomitingFAERS: 10
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
91Application site inflammationFAERS: 9US FAERS
92Application site scarFAERS: 9US FAERS
93Bladder painFAERS: 9SIDER
US FAERS
94Circumstance or information capable of leading to medication errorFAERS: 9US FAERS
95Inappropriate schedule of product administrationFAERS: 9US FAERS
96NasopharyngitisFAERS: 9OFFSIDES
SIDER
US FAERS
97NervousnessFAERS: 9
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
98Pain of skinFAERS: 9OFFSIDES
US FAERS
99Visual ImpairmentFAERS: 9
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
100AlopeciaFAERS: 8OFFSIDES
US FAERS
101Application site erosionFAERS: 8US FAERS
102DyspepsiaFAERS: 8OFFSIDES
SIDER
US FAERS
103FlatulenceFAERS: 8
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
104Product label issueFAERS: 8US FAERS
105Product use complaintFAERS: 8US FAERS
106SyncopeFAERS: 8SIDER
US FAERS
107VertigoFAERS: 8US FAERS
108Application site drynessFAERS: 7US FAERS
109Memory impairmentFAERS: 7SIDER
US FAERS
110Product package associated injuryFAERS: 7US FAERS
111Product packaging quantity issueFAERS: 7US FAERS
112Product physical issueFAERS: 7US FAERS
113Therapeutic response changedFAERS: 7US FAERS
114Cerebrovascular accidentFAERS: 6US FAERS
115Drug abuseFAERS: 6US FAERS
116Lip swellingFAERS: 6US FAERS
117TremorFAERS: 6US FAERS
118AngioedemaFAERS: 5SIDER
US FAERS
119Bladder spasmFAERS: 5OFFSIDES
US FAERS
120Blood urine presentFAERS: 5US FAERS
121ChillsFAERS: 5US FAERS
122Device adhesion issueFAERS: 5US FAERS
123Drug administered to patient of inappropriate ageFAERS: 5US FAERS
124DysphoniaFAERS: 5SIDER
US FAERS
125Eye painFAERS: 5SIDER
US FAERS
126HypotensionFAERS: 56510843CTD
SIDER
US FAERS
127Incorrect product storageFAERS: 5US FAERS
128InflammationFAERS: 5US FAERS
129Joint swellingFAERS: 5US FAERS
130LacerationFAERS: 5US FAERS
131No adverse eventFAERS: 5US FAERS
132AphasiaFAERS: 4US FAERS
133Application site dischargeFAERS: 4US FAERS
134Application site hypersensitivityFAERS: 4US FAERS
135Atrial FibrillationFAERS: 4US FAERS
136DementiaFAERS: 4US FAERS
137DiplopiaFAERS: 4US FAERS
138Drug toxicityFAERS: 4US FAERS
139IncontinenceFAERS: 4OFFSIDES
US FAERS
140PolyuriaFAERS: 4US FAERS
141Prescribed overdoseFAERS: 4US FAERS
142PresyncopeFAERS: 4US FAERS
143Therapeutic product ineffectiveFAERS: 4US FAERS
144Thermal burnFAERS: 4US FAERS
145Urinary hesitationFAERS: 4SIDER
US FAERS
146Weight decreasedFAERS: 4US FAERS
147treatment failureFAERS: 4US FAERS
148Acute kidney injuryFAERS: 3US FAERS
149Application site infectionFAERS: 3US FAERS
150Application site lacerationFAERS: 3US FAERS
151Application site scabFAERS: 3US FAERS
152Drug dispensing errorFAERS: 3US FAERS
153DysarthriaFAERS: 3US FAERS
154Eye irritationFAERS: 3SIDER
US FAERS
155Flank PainFAERS: 3SIDER
US FAERS
156Hallucinations, mixedFAERS: 3US FAERS
157HydronephrosisFAERS: 3OFFSIDES
US FAERS
158Impaired work abilityFAERS: 3US FAERS
159InfectionFAERS: 3SIDER
US FAERS
160Intentional drug misuseFAERS: 3US FAERS
161LethargyFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
162Medication residueFAERS: 3US FAERS
163Mental status changesFAERS: 3OFFSIDES
US FAERS
164Middle insomniaFAERS: 3US FAERS
165Musculoskeletal discomfortFAERS: 3SIDER
US FAERS
166Night sweatsFAERS: 3US FAERS
167Oral painFAERS: 3US FAERS
168Oropharyngeal painFAERS: 3SIDER
US FAERS
169PneumoniaFAERS: 3US FAERS
170Product administered at inappropriate siteFAERS: 3US FAERS
171Product dose omissionFAERS: 3US FAERS
172Product lot number issueFAERS: 3US FAERS
173Product prescribing errorFAERS: 3US FAERS
174RestlessnessFAERS: 3US FAERS
175Skin hypertrophyFAERS: 3OFFSIDES
US FAERS
176StomatitisFAERS: 3SIDER
US FAERS
177Urine output increasedFAERS: 3US FAERS
178AbasiaFAERS: 2OFFSIDES
US FAERS
179Accidental exposure to productFAERS: 2US FAERS
180Accidental overdoseFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
181AneurysmFAERS: 2US FAERS
182Anorectal discomfortFAERS: 2US FAERS
183Anticholinergic SyndromeFAERS: 2US FAERS
184AnuriaFAERS: 2US FAERS
185AphoniaFAERS: 2US FAERS
186Aphthous StomatitisFAERS: 2US FAERS
187Application site acneFAERS: 2US FAERS
188Application site noduleFAERS: 2US FAERS
189BoredomFAERS: 2US FAERS
190Chemical injuryFAERS: 2US FAERS
191Cor pulmonaleFAERS: 2US FAERS
192Corneal InfectionFAERS: 2US FAERS
193Creutzfeldt-Jakob diseaseFAERS: 2US FAERS
194CyanosisFAERS: 2US FAERS
195Dental cariesFAERS: 2OFFSIDES
US FAERS
196DependenceFAERS: 2US FAERS
197DermatitisFAERS: 2SIDER
US FAERS
198Device material issueFAERS: 2US FAERS
199Device use errorFAERS: 2US FAERS
200Disease recurrenceFAERS: 2US FAERS
201EnuresisFAERS: 2US FAERS
202EructationFAERS: 2SIDER
US FAERS
203Feeling jitteryFAERS: 2US FAERS
204Gastrointestinal PainFAERS: 2SIDER
US FAERS
205HypohidrosisFAERS: 2SIDER
US FAERS
206IleusFAERS: 2US FAERS
207Initial insomniaFAERS: 2US FAERS
208Intercepted drug dispensing errorFAERS: 2US FAERS
209LaryngitisFAERS: 2US FAERS
210Limb injuryFAERS: 2US FAERS
211Muscle strainFAERS: 2US FAERS
212Neck PainFAERS: 2US FAERS
213NephrolithiasisFAERS: 2US FAERS
214NoduleFAERS: 2US FAERS
215Ocular HypertensionFAERS: 2US FAERS
216PallorFAERS: 2US FAERS
217PolydipsiaFAERS: 2US FAERS
218Product dispensing errorFAERS: 2US FAERS
219Product use in unapproved indicationFAERS: 2US FAERS
220PyelonephritisFAERS: 2US FAERS
221Quality of life decreasedFAERS: 2OFFSIDES
US FAERS
222Renal painFAERS: 2US FAERS
223Respiratory FailureFAERS: 2US FAERS
224ScabFAERS: 2US FAERS
225SinusitisFAERS: 2OFFSIDES
SIDER
US FAERS
226Skin WrinklingFAERS: 2US FAERS
227Skin lesionFAERS: 2US FAERS
228TachycardiaFAERS: 26510843CTD
SIDER
US FAERS
229Therapy non-responderFAERS: 2US FAERS
230Throat irritationFAERS: 2US FAERS
231Urge IncontinenceFAERS: 2OFFSIDES
US FAERS
232VasculitisFAERS: 2US FAERS
233Vulvovaginal painFAERS: 2US FAERS
234Vulvovaginal pruritusFAERS: 2US FAERS
235WheezingFAERS: 2US FAERS
236Wrong drug administeredFAERS: 2US FAERS
237furuncleFAERS: 2US FAERS
238nervous system disorderFAERS: 2SIDER
US FAERS
239Abdominal tendernessFAERS: 1US FAERS
240Abnormal weight gainFAERS: 1US FAERS
241Accidental drug intake by childFAERS: 1US FAERS
242Accidental underdoseFAERS: 1US FAERS
243AcneFAERS: 1US FAERS
244Activities of daily living impairedFAERS: 1OFFSIDES
US FAERS
245Administration related reactionFAERS: 1US FAERS
246Adnexa uteri painFAERS: 1US FAERS
247AgeusiaFAERS: 1SIDER
US FAERS
248Anal FissureFAERS: 1US FAERS
249AngerFAERS: 1US FAERS
250Angina PectorisFAERS: 1US FAERS
251Angle Closure GlaucomaFAERS: 1SIDER
US FAERS
252AnhidrosisFAERS: 1OFFSIDES
US FAERS
253Ankle FractureFAERS: 1US FAERS
254Anorectal swellingFAERS: 1US FAERS
255AnorexiaFAERS: 1SIDER
US FAERS
256Application site eczemaFAERS: 1US FAERS
257Application site injuryFAERS: 1US FAERS
258Application site maculeFAERS: 1US FAERS
259Application site ulcerFAERS: 1US FAERS
260ArthritisFAERS: 1SIDER
US FAERS
261ArthropathyFAERS: 1SIDER
US FAERS
262AsterixisFAERS: 1OFFSIDES
US FAERS
263Atrial FlutterFAERS: 1US FAERS
264Automatic bladderFAERS: 1US FAERS
265Bacterial test positiveFAERS: 1US FAERS
266Basal cell carcinomaFAERS: 1US FAERS
267Bladder discomfortFAERS: 1OFFSIDES
US FAERS
268BlindnessFAERS: 118476934CTD
US FAERS
269Blood count abnormalFAERS: 1US FAERS
270Blood creatinine increasedFAERS: 1OFFSIDES
SIDER
US FAERS
271Blood glucose decreasedFAERS: 1US FAERS
272Blood glucose increasedFAERS: 1SIDER
US FAERS
273Blood pressure fluctuationFAERS: 1US FAERS
274Blood pressure inadequately controlledFAERS: 1US FAERS
275Bone painFAERS: 1OFFSIDES
US FAERS
276Bowel movement irregularityFAERS: 1US FAERS
277BradykinesiaFAERS: 1US FAERS
278BronchitisFAERS: 1OFFSIDES
SIDER
US FAERS
279BronchopneumoniaFAERS: 1US FAERS
280BronchospasmFAERS: 1US FAERS
281CachexiaFAERS: 1US FAERS
282CarcinomaFAERS: 1US FAERS
283Cardiac ArrestFAERS: 1US FAERS
284Cardiac FlutterFAERS: 1US FAERS
285Cardiac ablationFAERS: 1US FAERS
286Carpal Tunnel SyndromeFAERS: 1US FAERS
287CataractFAERS: 1OFFSIDES
US FAERS
288Cerebral InfarctionFAERS: 1US FAERS
289Cervical polypFAERS: 1US FAERS
290CheilitisFAERS: 1US FAERS
291Chest discomfortFAERS: 1SIDER
US FAERS
292ChokingFAERS: 1US FAERS
293ClumsinessFAERS: 1US FAERS
294Cold sweatFAERS: 1US FAERS
295ColitisFAERS: 1SIDER
US FAERS
296Contraindicated drug administeredFAERS: 1US FAERS
297Contraindicated product administeredFAERS: 1US FAERS
298Dark circles under eyesFAERS: 1US FAERS
299DeafnessFAERS: 1US FAERS
300Delusion of referenceFAERS: 1US FAERS
301Deprescribing errorFAERS: 1US FAERS
302Depressed Level of ConsciousnessFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
303Device difficult to useFAERS: 1US FAERS
304DisabilityFAERS: 1US FAERS
305DiverticulitisFAERS: 1US FAERS
306Drug screen false positiveFAERS: 1US FAERS
307Drug withdrawal syndromeFAERS: 1US FAERS
308DyscheziaFAERS: 1US FAERS
309Ear discomfortFAERS: 1OFFSIDES
US FAERS
310Economic problemFAERS: 1US FAERS
311Electromyogram abnormalFAERS: 1US FAERS
312Endodontic procedureFAERS: 1OFFSIDES
US FAERS
313Enterococcus test positiveFAERS: 1US FAERS
314Epidermal necrosisFAERS: 1US FAERS
315EpistaxisFAERS: 1SIDER
US FAERS
316Erectile dysfunctionFAERS: 1OFFSIDES
SIDER
US FAERS
317ErythromelalgiaFAERS: 1US FAERS
318Escherichia infectionFAERS: 1US FAERS
319Excessive eye blinkingFAERS: 1US FAERS
320ExcoriationFAERS: 1US FAERS
321Expired drug administeredFAERS: 1US FAERS
322Eye inflammationFAERS: 1US FAERS
323Eyelid exfoliationFAERS: 1US FAERS
324Feeling ColdFAERS: 1US FAERS
325Feelings of worthlessnessFAERS: 1US FAERS
326FlushingFAERS: 1SIDER
US FAERS
327Foreign body sensation in eyesFAERS: 1US FAERS
328FormicationFAERS: 1US FAERS
329Full blood count abnormalFAERS: 1US FAERS
330Gait inabilityFAERS: 1US FAERS
331Gastrointestinal hypomotilityFAERS: 1US FAERS
332Gastrointestinal motility disorderFAERS: 1US FAERS
333General symptomFAERS: 1US FAERS
334Gingival RecessionFAERS: 1US FAERS
335GlossitisFAERS: 1SIDER
US FAERS
336Gluten sensitivityFAERS: 1US FAERS
337Heat StrokeFAERS: 1SIDER
US FAERS
338HepatotoxicityFAERS: 1US FAERS
339HungerFAERS: 1US FAERS
340HypersomniaFAERS: 1US FAERS
341Impaired driving abilityFAERS: 1US FAERS
342Impaired gastric emptyingFAERS: 1US FAERS
343Incorrect drug dosage form administeredFAERS: 1US FAERS
344Incorrect route of drug administrationFAERS: 1US FAERS
345Infrequent bowel movementsFAERS: 1US FAERS
346Intentional misuseFAERS: 1US FAERS
347Intentional product use issueFAERS: 1US FAERS
348Intercepted drug prescribing errorFAERS: 1US FAERS
349Intercepted medication errorFAERS: 1US FAERS
350Intercepted product prescribing errorFAERS: 1US FAERS
351Intraocular pressure fluctuationFAERS: 1US FAERS
352Joint injuryFAERS: 1OFFSIDES
US FAERS
353Laboratory test interferenceFAERS: 1US FAERS
354Lacrimation decreasedFAERS: 1SIDER
US FAERS
355Leukocytoclastic vasculitisFAERS: 1US FAERS
356Lip exfoliationFAERS: 1US FAERS
357LymphadenopathyFAERS: 1US FAERS
358Macular degenerationFAERS: 1US FAERS
359Mastication disorderFAERS: 1US FAERS
360Mental disorder due to a general medical conditionFAERS: 1US FAERS
361Mental impairmentFAERS: 1US FAERS
362Migraine with AuraFAERS: 1US FAERS
363MiliariaFAERS: 1US FAERS
364Mouth swellingFAERS: 1US FAERS
365Multiple allergiesFAERS: 1US FAERS
366Muscle tightnessFAERS: 1US FAERS
367Musculoskeletal PainFAERS: 1US FAERS
368Musculoskeletal stiffnessFAERS: 1OFFSIDES
US FAERS
369Myasthenia GravisFAERS: 1US FAERS
370Myocardial InfarctionFAERS: 1US FAERS
371NeuralgiaFAERS: 1US FAERS
372Non-cardiac chest painFAERS: 1US FAERS
373Nonspecific reactionFAERS: 1US FAERS
374Ocular icterusFAERS: 1US FAERS
375OnychoclasisFAERS: 1US FAERS
376Optic NeuropathyFAERS: 1US FAERS
377Oral infectionFAERS: 1US FAERS
378Oral pruritusFAERS: 1US FAERS
379Packaging design issueFAERS: 1US FAERS
380PancreatitisFAERS: 1US FAERS
381PancytopeniaFAERS: 1US FAERS
382PapuleFAERS: 1US FAERS
383ParanoiaFAERS: 1SIDER
US FAERS
384Patella replacementFAERS: 1US FAERS
385Pelvic discomfortFAERS: 1OFFSIDES
US FAERS
386PericarditisFAERS: 1US FAERS
387Perineal erythemaFAERS: 1US FAERS
388Perineal painFAERS: 1US FAERS
389Pharmaceutical product counterfeitFAERS: 1US FAERS
390PharyngitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
391PhotophobiaFAERS: 1US FAERS
392Platelet count abnormalFAERS: 1US FAERS
393Poor quality sleepFAERS: 1US FAERS
394Pre-existing condition improvedFAERS: 1US FAERS
395Product availability issueFAERS: 1US FAERS
396Product distribution issueFAERS: 1US FAERS
397Product formulation issueFAERS: 1US FAERS
398Product label confusionFAERS: 1US FAERS
399Product measured potency issueFAERS: 1US FAERS
400Product outer packaging issueFAERS: 1US FAERS
401Product solubility abnormalFAERS: 1US FAERS
402Product storage errorFAERS: 1US FAERS
403Pruritus allergicFAERS: 1US FAERS
404Rectal fissureFAERS: 1US FAERS
405Respiratory distressFAERS: 1US FAERS
406Resting TremorFAERS: 1US FAERS
407RetchingFAERS: 1US FAERS
408Retinal Vein OcclusionFAERS: 1US FAERS
409RosaceaFAERS: 1US FAERS
410Senile dementiaFAERS: 1US FAERS
411Sensorimotor disorderFAERS: 1US FAERS
412SepsisFAERS: 1US FAERS
413Sinus TachycardiaFAERS: 1US FAERS
414Skin UlcerFAERS: 1US FAERS
415Skin discomfortFAERS: 1US FAERS
416Skin tightnessFAERS: 1OFFSIDES
US FAERS
417SluggishnessFAERS: 1US FAERS
418SneezingFAERS: 1US FAERS
419SomnambulismFAERS: 1US FAERS
420Specific gravity urine decreasedFAERS: 1US FAERS
421StrabismusFAERS: 1US FAERS
422SunburnFAERS: 1US FAERS
423Suprapubic painFAERS: 1US FAERS
424TensionFAERS: 1SIDER
US FAERS
425Therapeutic product effect decreasedFAERS: 1US FAERS
426Therapeutic response unexpected with drug substitutionFAERS: 1US FAERS
427TinnitusFAERS: 1OFFSIDES
SIDER
US FAERS
428Tongue discomfortFAERS: 1US FAERS
429TonsillitisFAERS: 1US FAERS
430ToothacheFAERS: 1US FAERS
431TrichorrhexisFAERS: 1US FAERS
432TrismusFAERS: 1US FAERS
433Unable to afford prescribed medicationFAERS: 1US FAERS
434Urinary bladder atrophyFAERS: 1US FAERS
435Urine flow decreasedFAERS: 1US FAERS
436Vaginal DischargeFAERS: 1US FAERS
437Vulvovaginal burning sensationFAERS: 1US FAERS
438Vulvovaginal discomfortFAERS: 1US FAERS
439Vulvovaginal drynessFAERS: 1US FAERS
440Vulvovaginal rashFAERS: 1US FAERS
441White blood cell count abnormalFAERS: 1OFFSIDES
US FAERS
442White blood cell count decreasedFAERS: 1US FAERS
443Wound ComplicationFAERS: 1US FAERS
444Wrong technique in device usage processFAERS: 1US FAERS
445muscle injuryFAERS: 1US FAERS
446AIDS Dementia ComplexOFFSIDES
447Abdominal sepsisOFFSIDES
448Abnormal visionOFFSIDES
SIDER
449Acid refluxOFFSIDES
450Acute bronchitisOFFSIDES
451Acute graft versus host disease in liverOFFSIDES
452Acute myocardial infarctionOFFSIDES
453Acute respiratory failureOFFSIDES
454AkathisiaSIDER
455AlveoloplastyOFFSIDES
456AmblyopiaSIDER
457Anaphylactic shockSIDER
458Anti-HBc IgG antibody positiveOFFSIDES
459Aortic AneurysmOFFSIDES
460Arthropod biteOFFSIDES
461ArthroscopyOFFSIDES
462Aspiration PneumoniaOFFSIDES
463AsthmaSIDER
464AtaxiaCanada Vigilance: 1Canada Vigilance
465Barium swallow abnormalOFFSIDES
466Beta 2 microglobulin increasedOFFSIDES
467Bipolar DisorderOFFSIDES
468Bipolar I disorderOFFSIDES
469Bloated feelingSIDER
470Blood 1,25-dihydroxycholecalciferol decreasedOFFSIDES
471Blood GlucoseOFFSIDES
472Blood cholesterolOFFSIDES
473Blood electrolytes decreasedOFFSIDES
474Blood iron increasedOFFSIDES
475Blood potassium decreasedOFFSIDES
476Blood triglycerides increasedOFFSIDES
477Body TemperatureOFFSIDES
478Bone lesionOFFSIDES
479Bone swellingOFFSIDES
480Brain scan abnormalOFFSIDES
481BursitisOFFSIDES
482Candida sepsisOFFSIDES
483Cardioactive drug level above therapeuticOFFSIDES
484Catalepsy10888308CTD
485Cataract operationOFFSIDES
486Catheter related infectionOFFSIDES
487CellulitisOFFSIDES
488Central nervous system lesionOFFSIDES
489Cerebral cystOFFSIDES
490Choking sensationOFFSIDES
491CholangiolitisOFFSIDES
492Chronic Obstructive Airway DiseaseOFFSIDES
493Circumoral paresthesiaSIDER
494Cognition Disorders9434659
18384584
CTD
495Completed SuicideOFFSIDES
496ConfabulationOFFSIDES
497Congenital tricuspid valve incompetenceOFFSIDES
498ConjunctivitisSIDER
499Creatinine increasedSIDER
500Cutaneous hypersensitivitySIDER
501CycloplegiaSIDER
502CystOFFSIDES
503DemyelinationOFFSIDES
504DermatomyositisOFFSIDES
505Detrusor instabilitySIDER
506Device malfunctionOFFSIDES
507DiabetesOFFSIDES
508Diabetes mellitus inadequate controlOFFSIDES
509Diabetic NephropathyOFFSIDES
510Dialysis disequilibrium syndromeOFFSIDES
511DiarrheaOFFSIDES
512Disturbance in sexual arousalSIDER
513DrowsinessSIDER
514DuodenitisOFFSIDES
515Ear and labyrinth disordersSIDER
516Early satietyOFFSIDES
517EcchymosisCanada Vigilance: 1Canada Vigilance
518Ejection Fraction DecreasedOFFSIDES
519Emergency CareOFFSIDES
520Emotional distressOFFSIDES
521EncephalomalaciaOFFSIDES
522EndometriosisOFFSIDES
523Enlargement abdomenSIDER
524Eosinophilic myocarditisOFFSIDES
525EpididymitisOFFSIDES
526EpiglottitisCanada Vigilance: 1Canada Vigilance
527Escherichia sepsisOFFSIDES
528Euphoric moodCanada Vigilance: 1Canada Vigilance
529Facial NeuralgiaOFFSIDES
530Failure to ThriveOFFSIDES
531FolliculitisOFFSIDES
532GamblingOFFSIDES
533GastroenteritisOFFSIDES
534General physical health deteriorationOFFSIDES
535Gingival blisterOFFSIDES
536GlaucomaSIDER
537Hallucinations8562668
17163294
CTD
538Haptoglobin DecreasedOFFSIDES
539Hepatic necrosisOFFSIDES
540HoarsenessSIDER
541Hyaluronic acid increasedOFFSIDES
542HydrocephalusOFFSIDES
543HyperkeratosisOFFSIDES
544HyperkinesiaSIDER
545Hypoaesthesia facialOFFSIDES
546HypokinesiaCanada Vigilance: 1Canada Vigilance
547Increased upper airway secretionSIDER
548Infected cystOFFSIDES
549InfestationSIDER
550Inflicted injurySIDER
551InfluenzaSIDER
552Infusion site mobility decreasedOFFSIDES
553Instillation site painOFFSIDES
554Intervertebral disc disorderOFFSIDES
555Intestinal infarctionOFFSIDES
556IritisSIDER
557Joint InstabilityOFFSIDES
558Joint Range of Motion DecreasedOFFSIDES
559Joint sprainOFFSIDES
560Joint stiffnessOFFSIDES
561Keratitis siccaOFFSIDES
562Keratoconjunctivitis SiccaSIDER
563Ligament ruptureOFFSIDES
564Lumbar radiculopathyOFFSIDES
565MaculeSIDER
566MalnutritionSIDER
567Markedly reduced dietary intakeOFFSIDES
568Memory Disorders17163294CTD
569Mood swingsSIDER
570Multiple sclerosis relapseOFFSIDES
571Muscle WeaknessOFFSIDES
572Musculoskeletal chest painOFFSIDES
573MydriasisSIDER
574MyelodysplasiaOFFSIDES
575Myeloma recurrenceOFFSIDES
576Nephrogenic Fibrosing DermopathyOFFSIDES
577Open woundOFFSIDES
578Optic Nerve GliomaOFFSIDES
579OsteomyelitisOFFSIDES
580Oxygen supplementationOFFSIDES
581ParaparesisOFFSIDES
582ParasomniaOFFSIDES
583Pericardial effusionOFFSIDES
584PeriodontitisOFFSIDES
585Personality ChangeCanada Vigilance: 1Canada Vigilance
586Pharyngeal swellingCanada Vigilance: 1Canada Vigilance
587Pharyngolaryngeal PainSIDER
588Physical disabilityOFFSIDES
589Pituitary enlargementOFFSIDES
590Post procedural infectionOFFSIDES
591Postictal headacheOFFSIDES
592Productive CoughOFFSIDES
593Psychoses, Substance-Induced17163294CTD
594Rectal ProlapseOFFSIDES
595Renal cystOFFSIDES
596Residual urine volumeSIDER
597Respiratory tract congestionOFFSIDES
598RhinitisOFFSIDES
SIDER
599SclerodactyliaOFFSIDES
600Seizures18476934CTD
601SequestrectomyOFFSIDES
602ShockSIDER
603Sinus ArrhythmiaSIDER
604Sinus headacheOFFSIDES
SIDER
605Skin IndurationOFFSIDES
606Soft tissue inflammationOFFSIDES
607Spinal column stenosisOFFSIDES
608Spinal fusion surgeryOFFSIDES
609Stem cell transplantOFFSIDES
610StressOFFSIDES
611Subcutaneous noduleOFFSIDES
612TenosynovitisSIDER
613ThrombocytopeniaCanada Vigilance: 1Canada Vigilance
614Tobacco userOFFSIDES
615Tooth ExtractionOFFSIDES
616Transaminases increasedOFFSIDES
617Transferrin saturation increasedOFFSIDES
618Urethritis noninfectiveSIDER
619UrethritisSIDER
620Vasodilation procedureSIDER
621VasodilationSIDER
622Vesiculobullous rashSIDER
623Walking aid userOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.